Arcosa Stockholders Approve $150/Share CRH Acquisition
ACA sits 63% above its 52-week low of $89.03.
Summary
Arcosa stockholders approved the all-cash acquisition by CRH at $150 per share at the special meeting on September 4, 2026. This clears a major hurdle toward closing, which is expected in Q1 2027 pending regulatory approvals. The vote follows the June 22 merger agreement and proxy filings, and comes despite two stockholder lawsuits and fifteen demand letters challenging disclosures. With the stock trading near its 52-week high of $146.92, the approval removes uncertainty around shareholder support. Final certified voting results will be filed on Form 8-K.
At the time of this announcement, ACA was trading at $145.45 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.1B. The 52-week trading range was $89.03 to $146.92. This news item was assessed with neutral market sentiment and an importance score of 9 out of 10. Source: BusinessWire.